Effect of motilin, somatostatin and bombesin on gastroduodenal myoelectric activity in sheep.
The effects of motilin, erythromycin, somatostatin and bombesin on antroduodenal myoelectric activity were investigated in conscious sheep. Myoelectric recordings were obtained from electrodes chronically implanted on the antrum and duodenal bulb. Peptides or erythromycin were infused intravenously (i.v.) during 5 min. Antagonists were injected i.v. as a bolus. Neither motilin (2.5-80 ng/kg/min) nor erythromycin (2-16 micrograms/kg/min) modified the antroduodenal myoelectric activity, although a single bolus of these compounds (250 ng/kg and 50 micrograms/kg respectively) increased the antral activity. Somatostatin at 5 ng/kg/min induced a decrease in the myoelectric activity of antrum and duodenum. However, doses of 10 to 40 ng/kg/min evoked a duodenal phase III-like activity with a subsequent quiescence period and a concomitant inhibition of the antral activity. These effects were reproduced by bombesin (2.5 to 40 ng/kg/min). Furthermore, an initial increase in the myoelectric activity and in the frequency of slow waves were recorded in the antrum when the highest doses were used. On the other hand, atropine (0.2 mg/kg) or hexamethonium (2 mg/kg) caused a long-lasting inhibition of antroduodenal myoelectric activity. These cholinergic antagonists abolished the effects induced by somatostatin (20 ng/kg/min) but not those evoked by bombesin but not motilin are putative modulators of the migrating myoelectric complex (MMC) in sheep. Moreover, a cholinergic neural pathway is involved in the somatostatin but not in the bombesin-induced effects.
Plaza
M A
MA
Departamento de Fisiología, Facultad de Veterinaria, Zaragoza, Spain.
Arruebo
M P
MP
Murillo
M D
MD
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001839:Bombesin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004386:Duodenum / Q000187:drug effects* / Q000502:physiology; D004569:Electroencephalography; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D018738:Hexamethonium / Q000494:pharmacology; D009037:Motilin / Q000494:pharmacology*; D012756:Sheep; D013004:Somatostatin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013270:Stomach / Q000187:drug effects* / Q000502:physiology
D018738:Hexamethonium; D013004:Somatostatin; D009037:Motilin; D004917:Erythromycin; D001285:Atropine; D001839:Bombesin